Alphamab Oncology Dividend
Dividend criteriumcontroles 0/6
Alphamab Oncology does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
-0.009%
Terugkoop Rendement
Totaal aandeelhoudersrendement | -0.009% |
Toekomstig dividendrendement | 0% |
Dividendgroei | n/a |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Uitbetalingsratio | n/a |
Recente dividendupdates
Geen updates
Recent updates
Alphamab Oncology (HKG:9966) Stocks Shoot Up 91% But Its P/S Still Looks Reasonable
Sep 30Some Alphamab Oncology (HKG:9966) Shareholders Look For Exit As Shares Take 48% Pounding
Jun 20Alphamab Oncology's (HKG:9966) Shares Climb 27% But Its Business Is Yet to Catch Up
May 06Optimistic Investors Push Alphamab Oncology (HKG:9966) Shares Up 27% But Growth Is Lacking
Mar 13Subdued Growth No Barrier To Alphamab Oncology's (HKG:9966) Price
Jan 17Slammed 40% Alphamab Oncology (HKG:9966) Screens Well Here But There Might Be A Catch
May 21Newsflash: Alphamab Oncology (HKG:9966) Analysts Have Been Trimming Their Revenue Forecasts
Mar 01Is Alphamab Oncology (HKG:9966) Using Debt Sensibly?
Oct 04Is Alphamab Oncology (HKG:9966) A Risky Investment?
May 21Rock star Growth Puts Alphamab Oncology (HKG:9966) In A Position To Use Debt
Oct 05Is Alphamab Oncology (HKG:9966) Using Too Much Debt?
May 05Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if 9966's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if 9966's dividend payments have been increasing.
Dividendrendement versus markt
Alphamab Oncology Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (9966) | n/a |
Markt onderkant 25% (HK) | 3.2% |
Markt Top 25% (HK) | 7.9% |
Gemiddelde industrie (Biotechs) | 1.1% |
Analist prognose (9966) (tot 3 jaar) | 0% |
Opmerkelijk dividend: Unable to evaluate 9966's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate 9966's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate 9966's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as 9966 has not reported any payouts.